On October 5, 2010, President Obama signed into law S. 1674, the Improving Access to Clinical Trials Act. The law provides for an exclusion under the Supplemental Security Income program and Medicaid for certain compensation of individuals who participate in clinical trials for rare diseases or conditions. In addition, on October 10, President Obama signed S. 3751, the Stem Cell Therapeutic and Research Reauthorization Act, which reauthorizes and makes changes to the National Cord Blood Inventory Program and the C.W. Bill Young Transplantation Program.